📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Hypnion

1.1 - Company Overview

Hypnion Logo

Hypnion

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of neuroscience drug discovery and development services focused on novel therapeutics for central nervous system disorders, including sleep and wake-alertness disorders and circadian rhythm abnormalities; offers SCORE-2004, a drug discovery platform.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Hypnion

CanniMed Logo

CanniMed

HQ: Canada Website
  • Description: Provider of standardized, pharmaceutical-grade medical cannabis in Canada, operating as a plant biopharmaceutical company under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CanniMed company profile →
Salvia BioElectronics Logo

Salvia BioElectronics

HQ: The Netherlands Website
  • Description: Provider of neuromodulation devices for migraine, including a paper-thin implant placed under the skin near nerves associated with migraine to deliver gentle electrical pulses, the MySalvia external device to activate therapy, and the MySalvia app for monitoring and personalized treatment; also exploring bioelectronic therapy for cluster headache.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Salvia BioElectronics company profile →
Vallon Pharmaceuticals Logo

Vallon Pharmaceuticals

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical development focused on new medications for central nervous system disorders, including ADAIR, an investigational novel abuse-deterrent formulation of amphetamine immediate release.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vallon Pharmaceuticals company profile →
SyntheticMR Logo

SyntheticMR

HQ: Sweden Website
  • Description: Provider of innovative magnetic resonance imaging software that supports shorter exam times and delivers more information to clinicians. Products include SyMRI NEURO for quantitative MRI with contrast images, tissue segmentation, and volumetric measurements in a single scan; SyMRI MSK for musculoskeletal imaging with quantitative maps and contrast images; and MAGiC, a GE Healthcare version offering customizable MRI imaging solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SyntheticMR company profile →
Oculogica Logo

Oculogica

HQ: United States Website
  • Description: Provider of neuro-diagnostic medical devices and training focused on TBI, concussion, and eye-tracking. Products include EyeBOX, an FDA-cleared, baseline-free, non-invasive device that tracks eye movements to aid in concussion (mTBI) diagnosis with results in under four minutes, and OcuPro, a roadside test for law enforcement to detect recent cannabis use and impairment. Offers EyeBOX training to customers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oculogica company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Hypnion

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Hypnion

2.2 - Growth funds investing in similar companies to Hypnion

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Hypnion

4.2 - Public trading comparable groups for Hypnion

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Hypnion

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Hypnion

What does Hypnion do?

Hypnion is a provider of neuroscience drug discovery and development services focused on novel therapeutics for central nervous system disorders, including sleep and wake-alertness disorders and circadian rhythm abnormalities; offers SCORE-2004, a drug discovery platform.

Who are Hypnion's competitors?

Hypnion's competitors and similar companies include CanniMed, Salvia BioElectronics, Vallon Pharmaceuticals, SyntheticMR, and Oculogica.

Where is Hypnion headquartered?

Hypnion is headquartered in United States.

How many employees does Hypnion have?

Hypnion has 1,000 employees 🔒.

When was Hypnion founded?

Hypnion was founded in 2010 🔒.

What sector and industry vertical is Hypnion in?

Hypnion is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Hypnion

Who are the top strategic acquirers in Hypnion's sector and industry

Top strategic M&A buyers and acquirers in Hypnion's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Hypnion?

Top strategic M&A buyers groups and sectors for Hypnion include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Hypnion's sector and industry vertical

Which are the top PE firms investing in Hypnion's sector and industry vertical?

Top PE firms investing in Hypnion's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Hypnion's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Hypnion's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Hypnion's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Hypnion include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Hypnion's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Hypnion?

The key public trading comparables and valuation benchmarks for Hypnion include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Hypnion for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Hypnion with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Hypnion's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Hypnion with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Hypnion's' sector and industry vertical?

Access recent funding rounds and capital raises in Hypnion's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Hypnion